TrialMolecular oncology2023

Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized trial.

Moa Egelberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.